Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

NIH - National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Center for Cancer Research
NCI Experimental Therapeutics Program (NExT)
Contact NExT
Show menu
Search this site
Last Updated: 10/17/14

CTEP

The Cancer Therapy Evaluation Program (CTEP) is responsible, within DCTD, for coordinating the largest, publicly funded oncology clinical trials organization in the world. CTEP has more than 900 active trials enrolling more than 20,000 study participants annually, nearly 250 grants and cooperative agreements, and about 100 investigational new drugs (INDs). CTEP's staff of almost 60 talented physicians, scientists, pharmacists, nurses, and regulatory specialists, assisted by multiple government contractors, work diligently to assure the safe, efficient, and ethical conduct of this complex research enterprise. CTEP-sponsored research spans Phase I through III trials of all cancer types and treatment modalities — chemotherapy, targeted agents, immunotherapy, radiation, and surgery.

To learn more about CTEP portfolio, please visit CTEP Active Agreements.